Oral arguments for who owns CRISPR-Cas9 start next month

The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9.
Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and pr. view full post